mohd izzuan / Getty Images People who inherit two copies of a gene variant called APOE4 have a 60% chance of developing Alzheimer’s by age 85. Only about 2% to 3% of people in the U.S. have this ...
The trial missed the primary endpoint of slowing cognitive decline in the overall study population. Topline results were announced from a phase 3 trial evaluating valiltramiprosate (ALZ-801) in ...
At the AAIC conference held 27 July to 1 August in Philadelphia, microglial epigenetics stood in the limelight. Microglia are infamous for their dynamic and varied responses to different threats they ...
Early, Sustained and Statistically Significant Reduction in Plasma P-tau 181 Reaching 31% at 24 Months Observed in Carriers of One or Two Copies of APOE4 Gene, who Represent Two Thirds of Alzheimer’s ...
Almost 30 years after its discovery as the most prominent risk factor for AD, ApoE continues to serve more questions than answers to the field. As evidenced by the many ApoE-focused presentations at ...
WASHINGTON, March 16, 2026 /PRNewswire/ -- ApoE4.Info, Inc and the ApoE4 Alzheimer's Alliance (A3) today announced a strategic partnership to elevate research, education, and public policy efforts ...
Please provide your email address to receive an email when new articles are posted on . People with the APOE4 genotype have a greater risk for developing Alzheimer’s disease. Consumption of green tea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results